Fibrodysplasia ossificans progressiva is an extremely rare connective tissue disorder in which fibrous connective tissue such as muscle, tendons and ligaments gradually ossifies into bone, progressively immobilizing the body as new bone replaces musculature and fuses with the skeleton; the condition is nicknamed stone man disease. It results from a mutation in the ACVR1 gene on chromosome 2, substituting arginine for histidine at codon 206 of the ACVR1 protein and causing abnormal activation that turns connective tissue into bone. Children typically experience a first flare up before age ten, often signaled by malformed big toes and painful soft tissue swelling, with bone growth generally progressing downward from the neck and shoulders to the arms, chest and feet. As of 2020 only 834 confirmed cases were known worldwide, an incidence of about 0.88 per million people, though underdiagnosis likely means the true number is higher.
Facts
Classification
ICD-10 ChapterXIII: Diseases of the Musculoskeletal System and Connective Tissue 1 Causative Agent
Causative Agent (category) Sources
1. World Health Organization: ICD-10 Version:2019 - M61.1
World Health OrganizationICD-10 2019 category M61.1, Chapter XIIIQuote, ICD-10 2019 category M61.1, Chapter XIII
M61.1 Myositis ossificans progressiva Incl.: Fibrodysplasia ossificans progressiva
View the Source 2. Fibrodysplasia ossificans progressiva (Wikipedia)
infobox causesQuote, infobox causes
causes: Heterozygous activating mutation in the ACVR1 gene
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.